Trial Profile
A placebo-controlled comparison of the efficacy and safety of the current US version of Pulmicort (budesonide) turbuhaler and the new version of Pulmicort turbuhaler in asthmatic adults currently treated with inhaled steroids
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2008
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Apr 2008 New trial record.